Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

San Bernardino, California 92404


Purpose:

Comparing the effect of switching from Lupron and Zoladex to Eligard. PSA and Testosterone levels are measured at set intervals to determine if Eligard is equal or better then Lupron or Zoladex in advanced Prostate Cancer patients.


Criteria:

Inclusion Criteria: Patient with Advanced Ca, on stable dose of Lupron or Zoladex Exclusion Criteria: - Previous exposure to Eligard.


NCT ID:

NCT00220194


Primary Contact:

Principal Investigator
Franklin M Chu, MD
San Bernfardino Urological Associates


Backup Contact:

N/A


Location Contact:

San Bernardino, California 92404
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: November 18, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.